• Wed, March 27, 2024

by: WOPRAI

Carter Gould Maintained (ABBV) at Buy with Increased Target to $195 on, Mar 27th, 2024

by: WOPRAI

Andrew Fein Maintained (ABOS) at Strong Buy and Held Target at $15 on, Mar 27th, 2024

by: WOPRAI

Douglas Tsao Maintained (ARGX) at Strong Buy and Held Target at $451 on, Mar 27th, 2024

by: WOPRAI

Graig Suvannavejh Maintained (APLS) at Hold and Held Target at $60 on, Mar 27th, 2024

by: WOPRAI

Katja Jancic Maintained (ARCH) at Buy and Held Target at $180 on, Mar 27th, 2024

by: WOPRAI

Arun Jayaram Maintained (AR) at Buy with Increased Target to $32 on, Mar 27th, 2024

by: WOPRAI

Joseph Pantginis Maintained (APTO) at Strong Buy and Held Target at $23 on, Mar 27th, 2024

by: WOPRAI

Robert Driscoll Maintained (APRE) at Buy with Increased Target to $11 on, Mar 27th, 2024

by: WOPRAI

Vamil Divan Downgraded (TVTX) to Hold on, Mar 27th, 2024

by: WOPRAI

Fahed Kunwar Downgraded (V) to Hold and Held Target at $307 on, Mar 27th, 2024

by: WOPRAI

Dan Dolev Maintained (V) at Hold and Held Target at $265 on, Mar 27th, 2024

by: WOPRAI

Andrew Fein Maintained (VIGL) at Strong Buy and Held Target at $24 on, Mar 27th, 2024

by: WOPRAI

Vamil Divan Maintained (VERA) at Strong Buy with Increased Target to $56 on, Mar 27th, 2024

by: WOPRAI

Rishi Jaluria Reiterated (VEEV) at Buy and Held Target at $250 on, Mar 27th, 2024

by: WOPRAI

Arthur He Maintained (BCAB) at Strong Buy with Decreased Target to $7 on, Mar 27th, 2024

by: WOPRAI

Michael Roxland Downgraded (BERY) to Hold and Decreased Target to $68 on, Mar 27th, 2024

by: WOPRAI

Kostas Biliouris Maintained (BEAM) at Buy and Held Target at $57 on, Mar 27th, 2024

by: WOPRAI

Biju Perincheril Maintained (BE) at Buy with Decreased Target to $16 on, Mar 27th, 2024

by: WOPRAI

Rebecca Liang Maintained (BGNE) at Hold with Decreased Target to $161 on, Mar 27th, 2024

by: WOPRAI

John Roberts Initiated (CBT) at Strong Buy and Held Target at $104 on, Mar 27th, 2024

by: WOPRAI

Patrick Trucchio Maintained (ATAI) at Strong Buy and Held Target at $20 on, Mar 27th, 2024

by: WOPRAI

Alexander Blostein Maintained (AMP) at Strong Buy with Increased Target to $488 on, Mar 27th, 2024

by: WOPRAI

Amit Daryanani Maintained (ANET) at Buy and Held Target at $300 on, Mar 27th, 2024

by: WOPRAI

Joseph Feldman Maintained (AMZN) at Buy and Held Target at $200 on, Mar 27th, 2024

by: WOPRAI

Derek Archila Maintained (ANNX) at Buy with Increased Target to $12 on, Mar 27th, 2024

by: WOPRAI

Andrew Fein Maintained (ANNX) at Strong Buy and Held Target at $30 on, Mar 27th, 2024

by: WOPRAI

Joseph Stringer Reiterated (ANNX) at Strong Buy and Held Target at $16 on, Mar 27th, 2024

by: WOPRAI

Brent Bracelin Maintained (ADBE) at Buy and Held Target at $700 on, Mar 27th, 2024

by: WOPRAI

Brian Schwartz Reiterated (ADBE) at Buy and Held Target at $660 on, Mar 27th, 2024

by: WOPRAI

Keith Bachman Maintained (ADBE) at Buy and Held Target at $610 on, Mar 27th, 2024

by: WOPRAI

Kirk Materne Maintained (ADBE) at Buy and Held Target at $650 on, Mar 27th, 2024

by: WOPRAI

Matthew Hedberg Reiterated (ADBE) at Buy and Held Target at $630 on, Mar 27th, 2024

by: WOPRAI

Gregg Moskowitz Reiterated (ADBE) at Strong Buy and Held Target at $680 on, Mar 27th, 2024

by: WOPRAI

Anthony Pettinari Initiated (BALL) at Hold and Held Target at $70 on, Mar 27th, 2024

by: WOPRAI

James Lee Maintained (BABA) at Strong Buy and Held Target at $95 on, Mar 27th, 2024

by: WOPRAI

Kostas Biliouris Maintained (ALNY) at Buy and Held Target at $234 on, Mar 27th, 2024

by: WOPRAI

Tim Moore Maintained (VNRX) at Strong Buy and Held Target at $4.5 on, Mar 27th, 2024

by: WOPRAI

Ross Osborn Reiterated (VNRX) at Buy and Held Target at $2.5 on, Mar 27th, 2024

by: WOPRAI

Jay Olson Maintained (VKTX) at Buy with Increased Target to $138 on, Mar 27th, 2024

by: WOPRAI

Crispin Love Maintained (VRTS) at Buy with Increased Target to $275 on, Mar 27th, 2024

by: WOPRAI

Josh Beck Initiated (ZIP) at Hold on, Mar 27th, 2024

by: WOPRAI

Yi Fu Lee Reiterated (ZS) at Hold and Held Target at $230 on, Mar 27th, 2024

by: WOPRAI

Anthony Powell Maintained (BXP) at Hold with Decreased Target to $66 on, Mar 27th, 2024

by: WOPRAI

Mark Palmer Reiterated (btdr) at Strong Buy and Held Target at $13 on, Mar 27th, 2024

by: WOPRAI

Caitlin Burrows Maintained (BRX) at Strong Buy with Decreased Target to $27 on, Mar 27th, 2024

by: WOPRAI

Mark Fitzgibbon Reiterated (BRKL) at Buy and Held Target at $12 on, Mar 27th, 2024

by: WOPRAI

Wood Lay Maintained (BOKF) at Hold and Held Target at $94 on, Mar 27th, 2024

by: WOPRAI

Jonathan Aschoff Maintained (BPTH) at Strong Buy with Increased Target to $40 on, Mar 27th, 2024

Robert Driscoll Maintained (APRE) at Buy with Increased Target to $11 on, Mar 27th, 2024

Robert Driscoll of Wedbush, Maintained "Aprea Therapeutics, Inc." (APRE) at Buy with Increased Target from $9 to $11 on, Mar 27th, 2024.

Robert has made no other calls on APRE in the last 4 months.



There is 1 other peer that has a rating on APRE. Out of the 1 peers that are also analyzing APRE, 0 agree with Robert's Rating of Hold.



This is the rating of the analyst that currently disagrees with Robert

  • Joseph Pantginis of "HC Wainwright & Co." Maintained at Strong Buy and Held Target at $20 on, Tuesday, March 26th, 2024